为常规临床应用验证和实施仅体质瘤外
Parth S Shah1, Edward G Hughes2, Shrey S Sukhadia3
1Laboratory for Clinical Genomics and Advanced Technology, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire; Genome Informatics, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire; Dartmouth Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
这项研究验证了DH-CancerSeq试验,这是一种用于癌症基因组测试的全外因组测序方法. 它提供了标准化,成本效益和临床可行的结果,与目标小组相比.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 下一代测序 (NGS) 对于癌症基因组测试至关重要,但由于各种需求和资源,它面临着机构挑战.
- 多样化的基因组会导致不平等的患者护理,这凸显了在没有限制性套件或昂贵的再验证的情况下需要标准化.
研究的目的:
- 为了验证和临床实施DH-CancerSeq试验,一种全新的全外因子测序方法.
- 为各种机构设置建立一个标准化,具有成本效益的基因组测试方法.
主要方法:
- 开发和验证DH-CancerSeq试验,一种仅用于瘤的全外因子测序试验.
- 整合信息学,以简化数据分析.
- 对DH-CancerSeq与经过验证的向基因小组进行比较分析.
主要成果:
- DH-CancerSeq试验显示了与现有的向基因组具有可比的输入要求,灵敏度和特异性.
- 保持了类似的周转时间,确保及时的患者护理.
- 在多种不同的机构环境中成功实现了临床实施.
结论:
- DH-CancerSeq试验为瘤基因组测试提供了一个标准化和验证的全外因组测序解决方案.
- 这种方法解决了资源变化的挑战,并在全球范围内促进公平的患者护理.
- DH-CancerSeq为传统的向面板提供了具有成本效益的替代方案,提高了临床效用.
更多相关视频
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11:02Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
